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The endosymbiont Wolbachia wAlbB induces refractoriness to Plasmodium falciparum
in Anopheles stephensi, the primary mosquito vector of human malaria in the Middle
East and South Asia. However, it remains unknown whether such refractoriness can
be extended to other malaria species. In particular, it was reported that under very
specific conditions, wAlbB can enhance Plasmodium infection in some hosts. Here,
we measured the impact of wAlbB on the rodent malaria parasite Plasmodium berghei
in A. stephensi by comparing the load of oocysts and sporozoites in midguts and
salivary glands, respectively, between wAlbB-infected and -uninfected mosquitoes. To
investigate whether wAlbB modulated mosquito immune defense against parasites, we
compared the expression of the immune genes, which were previously reported to
involve in antimalarial response, in both midguts and the remaining carcass tissues of
mosquitoes. The stable association of wAlbB with A. stephensi resulted in reduction of
parasites by more than half at the oocyst stage, and up to 91.8% at the sporzoite stage.
The anti-plasmodium immune genes, including TEP1, LRIM1, Toll pathway gene Rel1
and the effector Defensin 1, were induced by wAlbB in different mosquito body tissues.
These findings suggest that immune priming is a potential cause of wAlbB-mediated
antimalarial response in A. stephensi. More importantly, no evidence was found for any
enhancement of Plasmodium infection in A. stephensi stably infected with wAlbB. We
discuss these findings with possible implementations of Wolbachia for malaria control in
disease endemic areas.
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INTRODUCTION
Transmitted by Anopheles mosquitoes, malaria is one of the world’s deadliest diseases caused by
protozoan parasites of the genus Plasmodium. Although significant efforts and resources have
been devoted to malaria control, especially over the past decade, there are still 3.2 billion people
currently living in areas of high malaria risk, with about 214 million cases of clinical malaria and
438,000 malaria-related deaths in WHO (2015). Given the lack of a highly effective vaccine and the
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development of drug resistance in parasites and insecticide
resistance in mosquito vectors, there is an urgent need for
novel control strategies to target the vectors that are difficult
to control by the existing methods (The malERA Consultative
Group on Vector Control, 2011). One of the potential approaches
is to suppress or modify mosquito population using either
genetically modified techniques or the endosymbiotic bacterium
Wolbachia (Ito et al., 2002; The malERA Consultative Group on
Vector Control, 2011), which was recently tested for proof-of-
concept through field release to control mosquito-borne diseases
(Hoffmann et al., 2011; Carvalho et al., 2015; Mains et al., 2016).
Wolbachia spp. are intracellular alpha-proteobacteria closely
related to Rickettsia. Maternally inherited infections with
Wolbachia occur in an estimated 40–66% of insect species, and
approximately 28% of surveyed mosquito species (Kittayapong
et al., 2000; Ricci et al., 2002; Hilgenboecker et al., 2008; Zug and
Hammerstein, 2012). No native Wolbachia had been found in
the 38 surveyed Anopheles species until a recent report identified
a novel Wolbachia strain, related to but distinct from strains
infecting other arthropods, in Anopheles gambiae (Kittayapong
et al., 2000; Baldini et al., 2014; Bourtzis et al., 2014). Through the
cytoplasmic incompatibility (CI) mechanism, some Wolbachia
strains induce early embryonic death when a Wolbachia-infected
male mates with an uninfected female (Sinkins, 2004; Werren
et al., 2008). Thus, Wolbachia-infected male mosquitoes are
proposed to be released to induce incompatible (or sterile)
mating and reduce vector density below a threshold required
for disease transmission (Laven, 1967; Brelsfoard et al., 2008).
Because Wolbachia-infected females produce viable offspring
whether they mate with uninfected or infected males, CI
provides the infected females an advantage in reproduction
over the uninfected female, allowing Wolbachia to spread into
an uninfected population. With the ability of Wolbachia to
directly reduce malaria parasites in the Anopheles mosquito (Bian
et al., 2013), invasion of Wolbachia into vector populations
theoretically will reduce mosquito vector competence for malaria
parasites, resulting in intervention of disease transmission. The
feasibility of the above two strategies in disease control is
currently being tested to combat Zika and dengue through
field trials in many countries, including Australia, USA, China
and Brazil, using Aedes mosquitoes carrying different type of
Wolbachia (Hoffmann et al., 2011; Bourtzis et al., 2014; Xi and
Joshi, 2015; Dutra et al., 2016; Mains et al., 2016).
We previously generated the first maternally inheritable
Wolbachia infection in an Anopheles malaria vector by
transferring Wolbachia wAlbB from Aedes albopictus into
A. stephensi through embryonic microinjection, resulting in
establishment of the transinfected LB1 strain in 2011 (Bian et al.,
2013). Since then, wAlbB has been stably maintained in the
A. stephensi LB1 strain in the laboratory for more than 5 years,
displaying both perfect maternal transmission and the ability
to induce a nearly complete CI. Furthermore, wAlbB induces
refractoriness to the human malaria parasite Plasmodium
falciparum in the LB1 mosquito (Bian et al., 2013). This is
consistent with the observation that a stable wMelPop infection
reduced the infection of avian malaria parasite, P. gallinaceum,
in Aedes aegypti (Moreira et al., 2009). Without a stable infection
in Anopheles gambiae, a transient Wolbachia infection was used
as a model to study Wolbachia–Plasmodium interactions in this
mosquito species (Kambris et al., 2010; Hughes et al., 2011). This
transient infection differed from a stable infection in that it was
generated through adult intrathoracic injection and the infection
was lost in the subsequent generations. Consistently, a transient
wMelPop infection significantly reduced both P. falciparum and
Plasmodium berghei in A. gambiae (Kambris et al., 2010; Hughes
et al., 2011). Suppression of P. falciparum was also observed
in A. gambiae with a transient wAlbB infection (Hughes et al.,
2011). In addition, the observed reduction was associated with
induction of anti-Plasmodium immune genes, including TEP1
(Kambris et al., 2010).
However, the impact of Wolbachia on Plasmodium in
mosquito may differ, depending on the strain of Wolbachia,
the species of parasite and the environmental temperature.
In contrast to the pathogen interference described above, a
native wPip infection was claimed to enhance the avian malaria
parasite P. relictum in Culex pipiens mosquito (Zele et al.,
2014). A transient wAlbB infection was also reported to increase
the rodent parasite P. berghei oocyst load in the midgut of
A. gamibiae, and the P. yoelii oocyst load at 24◦C in A. stephensi
(Hughes et al., 2012; Murdock et al., 2014). It is known that
P. falciparum and P. berghei interact differently with mosquito
hosts and the other four human malaria species, P. malariae, P.
ovale, P. knowlesi, and P. vivax are phylogenetically more closely
related to P. berghei than they are to P. falciparum (Hughes
et al., 2014). This raises concerns whether Wolbachia-based
population replacement may enhance transmission of those
parasites (Hughes et al., 2014). Thus, it is essential to validate
the impact of a stable wAlbB infection on mosquito vector
competence for additional Plasmodium species in Anopheles
mosquitoes.
In this study, we compared the vector competence for
P. berghei between of Wolbachia-infected and -uninfected
A. stephensi by examining oocyst and sporozoite loads in
mosquito midguts and salivary glands, respectively. To confirm
whether Wolbachia was able to regulate expression of the host
immune genes, we compared the expression of several immune
genes, which are known to be involved in antimalarial response,
in both midguts and the remaining carcass tissues between
the LB1 strain and Wolbachia-uninfected A. stephensi. We
observed that wAlbB significantly reduced P. berghei at both
oocyst and sporozoite stage in LB1 mosquitoes. This reduction
was associated with induction of a number of anti-Plasmodium
immune genes, including TEP1, Rel1 and Defensin 1, in either
midgut or the carcass. Consistent with our previous studies
using blood-fed mosquitoes, there was no impact of wAlbB on
mosquito life span after taking P. berghei-infected blood meal.
MATERIALS AND METHODS
Mosquito Rearing
The wild-type A. stephensi LIS strain (Wolbachia-free),
A. stephensi LB1 strain (Wolbachia-infected) and the
aposymbiotic line LBT strain (Wolbachia-free; generated by
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tetracycline treatment of the LB1 strain to remove wAlbB) were
described previously (Bian et al., 2013) and maintained on sugar
solution at 27◦C and 85% humidity, with a 12-h/12-h light/dark
cycle, according to standard rearing procedures (Joshi et al.,
2014). Before the infection assay, females of both LBT and LB1
were outcrossed with LIS males for >4 generations. For colony
maintenance and Plasmodium infection assay, adult females were
fed on the blood of anesthetized mice (BALB/c) according to a
protocol (03/14-036-00) approved by Michigan State University
Institutional Animal Care and Use Committees.
P. berghei Infection Assay
Plasmodium berghei (ANKA 2.34 strain) parasites from frozen
stocks were administered intraperitoneally to donor mice. When
the parasitemias of donor mice reached 10–20%, infected blood
was collected by heart puncture, washed and diluted 2.5 times
with PBS. Then, 200 µl of this diluted blood was transferred
to naive mice via intraperitoneal injection. All mice were
4- to 6-week-old BALB/c females. Parasitemia and exflagellation
rates were assessed by light microscopy inspection of Giemsa-
stained thin smears obtained by tail snips before mice were
used for mosquito feeding. At 7–8 days post-emergence, 60–70
females were transferred into a 0.5-lt mesh-covered cardboard
cup and were deprived of sucrose solution for 1–2 h, then
allowed to feed on anesthetized mice infected with P. berghei
that exhibited 1–3 exflagellation events per field, as previously
described (Billker et al., 1997). All P. berghei-infected mosquitoes
and corresponding control mosquitoes were kept at 21◦C and
80% humidity. At 10 days post-blood feeding, mosquito midguts
were dissected and stained in 0.05% mercurochrome for at least
10–30 min, and the loads of P. berghei oocysts were quantified
under light microscopy at 10X magnification. At 21 days post-
infection, mosquito salivary glands were dissected to quantify the
infection intensity at the stage of sporzoite. The salivary glands
were transferred into a microfuge tube containing 120 µl of
PBS and homogenized gently for 30 s with a hand held pestle.
After centrifugation at 8,000 rpm for 10 min, 90 µl of the
supernatant was discarded. The sporozoites were resuspended in
a final volume of 30 µl of PBS, and 10 µl of this suspension was
used to count the sporozoites as described previously (Bian et al.,
2013).
RNA Extraction, cDNA Synthesis, and
qRT PCR
Seven- to nine-day-old non-blood fed females were dissected in
PBS and midguts and the remaining carcass tissues were collected
in TRIzol R© reagent (Life technologies) and stored at −80◦C until
RNA extraction. Each tissue had eight replicates, with samples of
five females from a cohort of mosquitoes pooled together to make
one replicate. The cDNA transcript was produced using Reverse
Transcription Kit (Invitrogen). Real time PCR was performed
using SYBR green kit (Qiagen sciences) and ABI Prism 7900HT
Sequence Detection System (Applied Biosystems). The data were
processed and analyzed with Applied Biosystems SDS2.3 software
and the obtained CT values were exported into the Excel program
to calculate the relative fold changes. The ribosomal protein
S6 (RPS6) was used as an internal control for normalization
of cDNA templates (Bian et al., 2013). Relative fold changes
in gene expression values between Wolbachia-infected (LB1)
and uninfected (LBT) tissues were obtained by using 2−11CT
method (Livak and Schmittgen, 2001). All primers used for
real-time PCR are listed in Supplementary Table S1.
Life Span Assays
After feeding on P. berghei-infected mice, LB1, LIS, and LBT
mosquitoes were sorted and transferred into 0.5-lt mesh-covered
cardboard cups, with at least 20 females for each of 2–4 replicates.
Cups were changed every 2 days to avoid the impact of fungi,
which may grow on the dead mosquitoes, on the data. Mortality
was recorded on daily basis until day 9 post-infection, when over
70% of death had occurred.
Statistical Analyses
Prior to analyses, the normality of the data sets was checked using
D’Agostino and Pearson omnibus normality test. The oocyst
and sprozoite data were not normally distributed. Thus, the
Mann–Whittney U-test based on median values were used for
analysis. The prevalence rates in mosquitoes, in terms of midgut
and salivary gland infection rates, were analyzed using Fisher’s
exact test and the expression values of the genes were analyzed
using Student’s t-test. Log-rank test was used to compare the
survivorship after mosquitoes took P. berghei-infected blood. All
the analysis was done using GraphPad Prism version 5.00.
RESULTS
wAlbB Reduces P. berghei Oocyst Loads
in Mosquito Midguts
We previously showed that a stable wAlbB infection reduced
P. falciparum oocyst loads in midguts of A. stephensi (Bian et al.,
2013). However, a transient wAlbB infection was reported to
increase P. berghei oocyst load in midguts of A. gambiae (Hughes
et al., 2012). In order to characterize the effect of wAlbB on vector
competence of A. stephensi for P. berghei, we compared the oocyst
levels between the wild-type LIS strain (Wolbachia-free) and LIS-
derived LB1 strain (wAlbB -infected) or between LB1 strain and
its aposymbiotic LBT strain at day 10 after they took an infectious
blood meal from mice. In all three experiments, LB1 mosquitoes
displayed a significant reduction in the oocyst loads, with a trend
of reduction in the infection prevalence, compared to the LIS or
LBT mosquitoes (Figure 1). Specifically, a significant reduction
in oocyst load was observed in midguts of LB1 mosquitoes
compared to those of LIS mosquitoes in both experiments 1 and
2 (Mann–Whitney U-test, P < 0.05 and < 0.01 in experiments 1
and 2, respectively) (Figures 1A,B and Supplementary Table S2).
The median number of oocysts was reduced by 55.6 and 63%
in LB1 midguts compared to LIS midguts in experiments 1
and 2, respectively. In experiment 3, a similar experiment was
performed to compare oocyst development in LB1 mosquitoes
and LBT strain. Consistently, there was a significant reduction in
oocyst load in midguts of LB1 mosquitoes compared to those of
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FIGURE 1 |Wolbachia wAlbB-mediated reduction in Plasmodium berghei oocyst load in LB1 midguts. P. berghei oocyst loads in midguts of Anophelus
stephensi LB1 strain and its infection prevalence (the percentage of mosquitoes that were infected at any level) are compared to those of LIS (A,B) and LBT strains
(C). Points represent the number of parasites from an individual mosquito and horizontal lines indicate the median number of parasites per tissue. P-value is
indicated based on Mann–Whitney test. (D) One representative midgut from LIS and LB1 strain is shown, with an arrow indicating the oocyst.
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LBT mosquitoes (Mann–Whitney U-test, P < 0.05) (Figure 1C
and Supplementary Table S2). These results indicate that wAlbB
interferes with P. berghei oocyst development in midguts of LB1
mosquitoes.
wAlbB Reduces P. berghei Sporozoite
Loads in Mosquito Salivary Glands
To further test whether mosquito’s potential to transmit
P. berghei was reduced by wAlbB, we compared the number
of sporozoites in the salivary glands of LB1 and LIS or LBT
mosquitoes at 21 days post-infection. In all three experiments,
there were significantly lower numbers of sporozoites, with a
trend of reduction in the infection prevalence, in the salivary
glands of LB1 mosquitoes than those of LIS or LBT mosquitoes
(Mann–Whitney U-test, P < 0.05) (Figure 2 and Supplementary
Table S2). In experiments 1 and 2, the median number of
sporozoites was reduced by 91.7 and 60.2%, respectively, in LB1
mosquitoes compared to LIS mosquitoes (Figures 2A,B and
Supplementary Table S2). In experiment 3, the median number of
sporozoites was reduced by 91.8% in LB1 mosquitoes compared
to LBT mosquitoes (Figure 2C and Supplementary Table S2).
These results indicate wAlbB interferes with P. berghei sporozoite
development in mosquito salivary glands.
wAlbB Induces Expression of
Anti-Plasmodium Immune Factors in
Mosquito
To explore the potential mechanism underlying wAlbB-mediated
Plasmodium interference, we selected six immune genes that
were previously reported to play roles in anti-Plasmodium
response (Blandin et al., 2004; Frolet et al., 2006; Povelones
et al., 2009) and compared their expression in both midguts
and the remaining carcass tissues of non-blood-fed mosquito
LB1 and LBT strains using qRT-PCR. As a result, we found that
expression of TEP1, Rel1, and PGRP-LC genes were significantly
induced by wAlbB in midguts (Figure 3A) and expression of
Def1, LRIM1, and CAT genes were significantly induced in the
carcass tissues (Figure 3B). These results indicate that wAlbB
may induce parasite interference through priming the mosquito’s
anti-Plasmodium immune system.
wAlbB Does Not Change the Life Span of
P. berghei-Infected Mosquitoes
We previously observed that wAlbB increased longevity of
LB1 mosquitoes when they were maintained using 10% sugar
solution (Joshi et al., 2014), resulting in a concern because
infectious mosquitoes with increased longevity may facilitate
disease transmission (Killeen et al., 2013). Thus, we compared the
life spans of LB1, LIS, and LBT mosquitoes after they took the
P. berghei-infected blood meal. All three strains showed a high
mortality within 2 days after taking the blood meal and thereafter
maintained a low mortality (Figure 4). There were no statistical
differences in survivorship among LB1, LIS, and LBT mosquitoes
(log-rank test, P > 0.05). Taken together with the observation of
no change in LB1 female longevity after taking uninfected blood
(Joshi et al., 2014), our results confirm that wAlbB-associated
increase in mosquito survivorship will occur only in males or
females that have not taken blood.
DISCUSSION
We have previously shown that wAlbB interferes with
P. falciparum in the A. stephensi LB1 strain (Bian et al., 2013).
In order to better characterize the spectrum of wAlbB-mediated
Plasmodium interference, we examined the impact of wAlbB on
P. berghei development in LB1 mosquitoes in this study. We
found that wAlbB reduced both oocyst and sporozoite loads in
midguts and salivary glands, respectively, of LB1 mosquitoes.
Furthermore, this reduction was associated with up-regulation of
a number of anti-Plasmodium immune genes, including TEP1,
Rel1 and Def1, in LB1 mosquitoes. We also showed that wAlbB
infection did not increase the life span of mosquitoes after taking
P. berghei -infected blood. These results support the potential to
develop Wolbachia-based strategy for malaria control.
The strength of wAlbB-mediated reduction in P. berghei
infection is similar to what was previously observed on
P. falciparum infection (Bian et al., 2013). The oocyst load of
both P. berghei and P. falciparum was reduced by more than half
in LB1 midguts compared to LIS midguts. For both parasites,
there was stronger reduction in the sporozoite stage than in the
oocyst stage. The reduction in P. berghei sporozoite levels ranged
between 71.1 and 91.8% as shown in the three experiments while
P. falciparum sporozoite levels were reduced by 70.9% in the
previous studies. Thus, these results indicate that wAlbB reduces
P. berghei infection as effectively as P. falciparum infection in LB1
mosquitoes.
The ability of wAlbB to reduce both P. berghei and
P. falciparum in A. stephensi indicates that wAlbB may
target common host factors that are essential for Plasmodium
development in mosquitoes. Two main hypotheses have been
proposed to understand the mechanism of Wolbachia-mediated
pathogen interference in insect hosts (Bourtzis et al., 2014; Xi
and Joshi, 2015). First, Wolbachia primes host immunity such
that it can effectively react to inhibit the subsequent pathogen
invasion. This is supported by the fact that a number of immune
genes, including Toll pathway genes and redox genes, were
induced by Wolbachia in the transinfected lines (Pan et al.,
2012). Second, Wolbachia outcompetes pathogens in utilizing
host metabolic pathway/components for its intracellular growth.
For example, Wolbachia replication is cholesterol-dependent,
requiring cholesterol-rich host membranes to form the vacuole
surrounding each bacterium (Caragata et al., 2013). This could
lead to a competition for cholesterol between Wolbachia and
pathogens (Atella et al., 2009).
To test the first hypothesis, we compared the expression of
six immune genes that were reported to be involved in blocking
of human and mouse malaria in A. gambiae (Blandin et al.,
2004; Frolet et al., 2006; Povelones et al., 2009). We found
that TEP1, PGRP-LC, and REL1 were induced in the midgut
while CAT1, Def1, and LRIM1 were up-regulated in the carcass.
Among them, TEP1 and Def1 were induced 2.7- and 4.2-fold,
respectively, by wAlbB in LB1 mosquitoes. These results are
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FIGURE 2 |Wolbachia wAlbB-mediated reduction in P. berghei sporozoite loads in LB1 salivary glands. P. berghei sporozoite loads in salivary glands of
A. stephensi LB1 strain and its infection prevalence are compared to those of LIS (A,B) and LBT strains (C). Points represent the number of parasites from an
individual mosquito and horizontal lines indicate the median number of parasites per tissue. P-value is indicated based on Mann–Whitney test. (D) One
representative salivary glands from LIS and LB1 strain is shown, with an arrow indicating the sporozoite.
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FIGURE 3 | Up-regulation of anti-Plasmodium immune genes by wAlbB in LB1 mosquito. qRT-PCR was used to assess the expression of each of the
selected anti-Plasmodium immune genes in either midguts (A) or the remaining carcass tissues (B), with the host RPS6 as an internal reference control to normalize
the data. 2−11CT method was used to calculate fold change for each gene and significance was determined based on comparison of 1CT of each gene in LB1 and
LBT. P-value is indicated based on Mann–Whitney test.
consistent with the previous studies using A. gambiae with a
transient somatic wMelPop infection and a stably infected cell
line, in which wMelPop strongly induced the expression of TEP1,
LRIM1, and Def1 (Kambris et al., 2010). Further studies show that
a recombinant Wolbachia surface protein (WSP) is sufficient to
induce the expression of those malaria-related immune genes in
both Anopheles and Aedes cell lines (Pinto et al., 2012).
As a well-characterized complement-like molecule in the
anti-parasitic defense of mosquitoes, TEP1 plays a central role
in defense against gram negative bacteria, P. falciparum and
P. berghei in Anopheles mosquitoes. With the capacity to reduce
the oocyst burden by either direct killing or melanization process,
TEP1 was described as major determinant of vectorial capacity
for Plasmodium in A. gambiae (Blandin et al., 2004). Knocking
down TEP1 gene expression has resulted in several fold increase
in the midgut oocyst load (Dong et al., 2006; Frolet et al., 2006).
In A. gambiae, Leucine-rich Repeat (LRR) proteins, LRIM1, and
APL1C, form complexes to facilitate recognition of the parasite
by TEP1, resulting in parasite killing either by a lytic mechanism
or by arresting their development through melanization (Fraiture
et al., 2009; Povelones et al., 2009). Consistently, LRIM1 was
observed to be up-regulated by wAlbB in the carcass of LB1
mosquitoes. However, the orthologes of the A. gambiae sub
family APL genes (APL1-A, APL1-B, and APL1-C) are absent in
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FIGURE 4 | The impact of wAlbB on the life span of LB1 after taking the
P. berghei-infected blood meal. After LB1, LIS, and LBT mosquitoes were
infected by P. berghei, dead mosquitoes were removed and recorded every
day. The curves represent the mean percentage of mosquitoes surviving from
different biological replicates each day. There was no significant difference in
the life span of the infected females between LB1, LIS, and LBT mosquitoes.
the genome of A. stephensi (Jiang et al., 2014). It is unknown
whether another molecule plays a role similar to APL1C to
form a comparable complex in A. stephensi. Evidence has shown
that boosting NF-Kappa B factors (REL1 and REL2) induces
production of TEP1 in A. gambiae (Frolet et al., 2006). We
observed that REL1 and IMD pathway gene PGRP-LC were also
up-regulated by wAlbB in LB1 mosquitoes. Activation of Toll and
IMD pathways by wAlbB was further supported by a strong up-
regulation of expression of the antimicrobial peptide DEF1. DEF1
has a profound effect on development of oocysts and sporozoites.
Previous studies have shown that either injection or over-
expression of defensin in A. aegypti reduced both Plasmodium
oocyst in midgut and sporozoite in salivary gland (Shahabuddin
et al., 1998; Kokoza et al., 2010).
We previously found that the levels of ROS were significantly
higher in midguts and fat bodies of LB1 mosquitoes than in
those of LIS mosquitoes and nearly twofold higher in the whole
body of LB1 than in that of LIS mosquitoes (Bian et al., 2013).
Interestingly, midgut epithelial nitration has been shown to
work as an opsonization system that promotes activation of the
mosquito complement cascade (Kumar et al., 2010). It would
be interested to know whether epithelial nitration is increased
in Plasmodium-infected midguts of LB1 mosquitoes, resulting
in enhancement of TEP1-mediated lysis for anti-Plamsmodial
immunity. Increased production of ROS can lead to melanization
of parasites in an A. gabmbiae refractory strain (L3 strain)
(Kumar et al., 2003). However, we did not observe the deposition
of the melanin pigment on the surface of the oocysts in midguts
of the LB1 strain.
While we saw that wAlbB reduced P. berghei at both oocyst
and sporozoite stages in LB1 mosquito, in contrast it was reported
that A. gambiae with a transient wAlbB infection enhanced
P. berghei oocyst load (Hughes et al., 2012). The same group
also reported that the number of P. yoelii oocyst increased in
A. stephensi with a transient wAlbB infection at 24◦C although
wAlbB reduced the parasite at warmer temperatures (Murdock
et al., 2014). We think that they are likely to be artifacts associated
with their used transient infection system, in which Wolbachia
infection cannot pass to mosquito offspring because a barrier
appears to block the ability of Wolbachia to infect the germ
line. Mosquito lines with stable maternal inheritable infections
are generated through embryonic microinjection, during which
Wolbachia is introduced into germ plasm before the germ cells
are formed in the early embryo. Because only a small percentage
of the surviving individuals will have acquired a germ-line
Wolbachia infection through this process, a further intensive
screen is carried out to identify a stably infected line, which can
maternally transmit Wolbachia to the next generations at 100%
efficiency. Thus, a stable infection system has passed through a
restricted selection process that results in both Wolbachia and
its host being able to adapt to each other and to maintain their
co-existence. It is possible that only a subset of the variants in a
population ofWolbachia have been selected to form the symbiosis
in the stable infection system. Some Wolbachia may not be able
to form symbiosis due to inability to adapt to the new host,
which usually occurs when Wolbachia is transferred between
phylogenetically distant hosts. The requirement for embryonic
injection to generate a stable infection in mosquito may indicate
that early contact between Wolbachia and the host (i.e., earlier
than the development of the host immune system) may be
important in shaping the host’s immune system so thatWolbachia
can be persistently maintained in a new host. In a transient
infection system, the process of selection, adaptation, symbiosis
formation, and shaping of the host immune system is avoided,
thus, it can represent a very different type of system than that of a
stably infected system.
When evaluating the impact of Wolbachia on mosquito
vector competence, we think that two gold standards should
be used. First, only mosquito with a stable Wolbachia infection
should be used to provide conclusive evidence on whether
pathogen interference will occur. This is because only stably
infected mosquito can be developed for implementation in
disease control, and as described above, the transient infection
system does not accurately mimic the stable infection system.
Thus conflicting results can be misleading and damage the
public perception about the ongoing field trials and future
implementation of this control method. Second, the impact of
Wolbachia on mosquito vector competence should focus on the
pathogen transmission stage. This means direct measurement
of the number and infectiousness of pathogens that will be
transmitted from mosquito to vertebrate host, such as those in
mosquito saliva or salivary gland. When Plasmodia enter and
develop in the midgut, disseminate through hemolymph, and
infect the salivary gland, they will be attacked by Wolbachia-
mediated interference at each stage because Wolbachia has
preoccupied those tissues and induced hostile environment either
in tissue-specific (e.g., in midgut and salivary gland) or systemic
(e.g., in fat body) ways. An accumulated effect will be observed
best at the final transmission stage. It is possible that no reduction
or even slight enhancement could be observed in the midgut but
strong inhibition still occurs in saliva or salivary gland.
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Anopheles stephensi is an interesting model species for these
studies as its delay in producing a peritrophic matrix (PM,
chitin/protein matrix that forms around the blood meal in the
gut), which is more than twice as long as that of A. gambiae
(Freyvogel and Staeubli, 1965). This PM barrier delay results in
many more motile ookinetes escaping the gut to form oocysts.
Presence of these large number of oocysts (>100s) in a mosquito
is laboratory effect because in the field (as seen with other
Anopheles species and human Plasmodium sp.) only one or
a couple of oocysts are normally found on the midgut in a
potentially infectious field collected Anopheles (Sinden et al.,
2004). Thus a reduction in oocysts by 50% can mean a lot in the
field – however as an oocyst can produce over 1,000 sporozoites, it
is likely not the number of oocysts that make a mosquito infective.
It would be interested to determine the level of inhibition that is
sufficient for Wolbachia to interfere with disease transmission in
the field.
The two stable Wolbachia-infected mosquitoes examined
to date show resistances to malaria parasites, including
P. falciparum, P. berghei, and P. gallinaceum (Moreira et al., 2009;
Bian et al., 2013). It is argued that this resistance occurs only
in recent Wolbachia-host associations and will disappear during
the long-term evolution of novel Wolbachia-host associations
in mosquitoes. A recent study has discovered a marginally
higher number of the avian malaria parasite P. relictum in
Culex pipiens mosquito with native wPip infection as compared
to its aposymbiotic strain derived from antibiotic treatment,
resulting in a speculation that those transinfected mosquitoes
may evolve to be a better malaria vector (Zele et al., 2014). We
think that it is too early to make this prediction because many
other reasons, such as host body size and genetic background,
cannot be excluded to cause the subtle increase observed
in that study. In addition, antibiotic treatment to remove
Wolbachia has a systemic effect on the whole microbiome of
an organism and may result in a multitude of effects especially
on the immune system and infection responses. Currently,
it is difficult to design laboratory experiments to mimic this
long-term evolution process. What we know, however, is that
Wolbachia-mediated pathogen interference has been maintained
for >12 years in A. aegypt and >5 years in A. stephensi
in laboratory conditions. Here, we may be able to learn
from the Mycobacterium bovis bacille Calmette–Guérin (BCG)
vaccine against tuberculosis (TB). Although BCG is protective
for only 10–20 years, it has maintained its position as the
world’s most widely used vaccine (Andersen and Doherty,
2005). The ability to both generate a better mosquito strain
with improved pathogen blocking and repeatedly spread novel
Wolbachia into population will allow us to develop either a
better strain to replace the old one or a method to boost
its effectiveness should the pathogen interference decline over
time.
CONCLUSION
We have shown that a maternal inheritable wAlbB infection can
reduce P. berghei in A. stephensi. This pathogen interference
is associated with up-regulation of TEP1, LRIM1, REL1 and
the other anti-Plasmodium immune genes. wAlbB has no
impact on the longevity of females after taking infected blood
meal although it increases male mosquito survivorship (Joshi
et al., 2014). Future studies will investigate the contribution
of those up-regulated immune genes to the overall effect of
Wolbachia-mediated Plasmodium interference. Understanding
of the mechanism of Wolbachia-host interactions will facilitate
the development of transinfected mosquito strains with
strong pathogen blocking, low fitness cost, stable maternal
transmission and complete CI expression. Because there
are overlaps in distribution of the parasite P. vivax and
A. stephensi, future studies should also characterize the
impact of wAlbB on vector competence for P. vivax. Since
the endosymbiotic bacterium Wolbachia was introduced into
the primary dengue vector, a global effort, with field trials
ongoing in eight countries, has been initiated to develop
Wolbachia for dengue control. Like the primary dengue vector
A. aegypti, A. stephensi is an urban vector, which allows the
transfer our experience from the dengue control field trials to
malaria control field trials with this mosquito species more
likely to succeed. The ability of wAlbB to stably infect an
Anopheles malaria vector, induce a complete CI and confer
mosquito resistance to malaria parasite has opened an exciting
opportunity to develop Wolbachia-based strategy for malaria
control.
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